SAKAR HEALTHCARE
Back to Balance Sheet
|
SAKAR HEALTHCARE Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹67 Cr | ₹67 Cr | ₹108 Cr | ₹94 Cr | ₹46 Cr |
What is the latest Total Non-Current Liabilities ratio of SAKAR HEALTHCARE ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹67 Cr |
| Mar2024 | ₹67 Cr |
| Mar2023 | ₹108 Cr |
| Mar2022 | ₹94 Cr |
| Mar2021 | ₹46 Cr |
How is Total Non-Current Liabilities of SAKAR HEALTHCARE Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹67 Cr | -0.99 | |
| Mar2024 | ₹67 Cr | -38.00 | |
| Mar2023 | ₹108 Cr | 15.99 | |
| Mar2022 | ₹94 Cr | 103.03 | |
| Mar2021 | ₹46 Cr | - | |
Compare Total Non-Current Liabilities of peers of SAKAR HEALTHCARE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SAKAR HEALTHCARE | ₹882.2 Cr | 2.6% | -2.3% | 27% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹428,581.0 Cr | -1.8% | 4.1% | -1.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,051.0 Cr | -2.8% | -3.7% | 2.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹128,367.0 Cr | -0.2% | -0.9% | 12.9% | Stock Analytics | |
| CIPLA | ₹120,289.0 Cr | -2.1% | -1.7% | 0.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,421.0 Cr | -2% | 3.3% | -0.6% | Stock Analytics | |
SAKAR HEALTHCARE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SAKAR HEALTHCARE | 2.6% |
-2.3% |
27% |
| SENSEX | -0.8% |
1% |
3.2% |
You may also like the below Video Courses